Janus Family kinase (JAK) inhibitors in HLH and severe COVID-19

Am J Hematol. 2020 Dec;95(12):1448-1451. doi: 10.1002/ajh.25985. Epub 2020 Sep 30.

Author

Ryan A Wilcox¹

Affiliation

¹ Division of Hematology/Oncology, University of Michigan Cancer Center, Ann Arbor, Michigan.

PMID: 32918336
DOI: 10.1002/ajh.25985

No abstract available

Publication types

Editorial

MeSH terms

Animals
COVID-19 / immunology
COVID-19 Drug Treatment*
Humans
Janus Kinases / antagonists & inhibitors*
Lymphohistiocytosis, Hemophagocytic / drug therapy*
Lymphohistiocytosis, Hemophagocytic / immunology
Macrophages / immunology
Mice
Monocytes / immunology
Pandemics
Protein Kinase Inhibitors / therapeutic use*
SARS-CoV-2 / immunology*

Substances

Protein Kinase Inhibitors
Janus Kinases